Hormones and Breast Cancer: Volume 93

Hormones and Breast Cancer: Volume 93

Edited by 

Free delivery worldwide

Available. Dispatched from the UK in 2 business days
When will my order arrive?


First published in 1943, Vitamins and Hormones is the longest-running serial published by Academic Press. The Editorial Board now reflects expertise in the field of hormone action, vitamin action, X-ray crystal structure, physiology and enzyme mechanisms.

Under the capable and qualified editorial leadership of Dr. Gerald Litwack, Vitamins and Hormones continues to publish cutting-edge reviews of interest to endocrinologists, biochemists, nutritionists, pharmacologists, cell biologists and molecular biologists. Others interested in the structure and function of biologically active molecules like hormones and vitamins will, as always, turn to this series for comprehensive reviews by leading contributors to this and related disciplines.

This volume focuses on hormones and breast cancer.
show more

Product details

  • Hardback | 424 pages
  • 152.4 x 231.14 x 25.4mm | 544.31g
  • Academic Press Inc
  • San Diego, United States
  • English
  • New
  • 0124166733
  • 9780124166738

Table of contents

Sex Hormone Receptors in Breast Cancer Nina D'Abreo and Alexander A. Hindenburg

Role of KLF5 in Hormonal Signaling and Breast Cancer Development Rong Liu, Jin-Tang Dong, and Ceshi Chen

Adherence Rates and Correlates in Long-Term Hormonal Therapy Julia Dunn and Carolyn Gotay

Modulation of Estrogen Receptor Alpha Activity and Expression during Breast Cancer Progression Gwenneg Kerdivel, Gilles Flouriot, and Farzad Pakdel

Alpha-Actinin 4 and Tumorigenesis of Breast Cancer Kuo-Sheng Hsu and Hung-Ying Kao

FOXP1 and Estrogen Signaling in Breast Cancer Nobuhiro Ijichi, Kazuhiro Ikeda, Kuniko Horie-Inoue, and Satoshi Inoue

Estrogen-Mediated Mechanisms to Control the Growth and Apoptosis of Breast Cancer Cells: A Translational Research Success Story Russell E. McDaniel, Philipp Y. Maximov, and V. Craig Jordan

Dynamic Regulation of Steroid Hormone Receptor Transcriptional Activity by Reversible SUMOylation Todd P. Knutson and Carol A. Lange

Targeting Progesterone Receptors in Breast Cancer Sebastian Giulianelli, Alfredo Molinolo, and Claudia Lanari

The Epidemiology and Molecular Mechanisms Linking Obesity, Diabetes and Cancer Rosalyn D. Ferguson, Emily J. Gallagher, Eyal Scheinman, Rawan Damouni, and Derek LeRoith

Beta-Endorphin Neuron Regulates Stress Response and Innate Immunity to Prevent Breast Cancer Growth and Progression Dipak K. Sarkar and Changqing Zhang

The Hyperplastic Phenotype in Pr-A and Pr-B Transgenic Mice: Lessons on the Role of Estrogen and Progesterone Receptors in the Mouse Mammary Gland and Breast Cancer Rocio Sampayo, Sol Recouvreux, and Marina Simian

The Functional Role of Notch Signaling in Triple Negative Breast Cancer Jodi J. Speiser, Cagatay Ersahin, and Clodia Osipo

Adam22 as a Prognostic and Therapeutic Drug Target in the Treatment of Endocrine-Resistant Breast Cancer Jarlath C. Bolger and Leonie S. Young
show more

About Gerald Litwack

Following a liberal arts education with a major in chemistry and biology at Hobart College, Gerald (Gerry) Litwack earned M.S. and PhD degrees in biochemistry from the University of Wisconsin, Madison where he served as a Lecturer in Enzymology before starting a postdoctoral fellowship from the National Foundation for Infantile Paralysis at the Biochemical Institute of the Sorbonne in Paris. His first academic position was assistant professor of biochemistry at Rutgers University where he started his work on hormone action for six years. During this period, he did a sabbatical at the University of California, Berkeley, where he concentrated on rapid enzyme kinetics. In 1960 he accepted an offer of an associate professorship at the University of Pennsylvania Graduate School of Medicine. In 1964, he was invited to be full professor of biochemistry at The Fels Institute for Cancer Research and Molecular Biology at Temple Medical School, simultaneously with a Career Development Award from the NIH, where he later was named Deputy Director of the Institute and the Laura H. Carnell Professor in biochemistry. Subsequently, he was given the Faculty Research Award. He co-discovered ligandin, later found to be in the family of glutathione S-transferases, enzymes that protect the body from carcinogens. In 1991, he moved to the Jefferson Medical College at Thomas Jefferson University as Professor of Biochemistry, Chair of the Department of Pharmacology and Deputy Director of the Kimmel Cancer Research Institute. Later, he became chair of the combined Department of Biochemistry and Molecular Pharmacology and concurrently held the position of Vice Dean for Research. In 2003, he moved to Los Angeles and from 2004-2006 was a Visiting Scholar at the University of California, Los Angeles, in the Department of Biological Chemistry of the Geffen School of Medicine and, in this period, wrote "Human Biochemistry and Disease" a volume of 1254 pages. In 2007, he moved to Scranton, Pennsylvania, as Founding Chair of Basic Sciences and Acting Associate Dean for Research to start a new medical school, The Commonwealth Medical College. Having completing his mission in 2010, he moved to The Institute for Regenerative Medicine, Texas A & M Health Science Center, as Professor of Biochemistry and Associate Director. Currently, he is retired and lives in North Hollywood, California, where he continues as an author and as Series Editor of Vitamins and Hormones. He is involved in writing another textbook and has written a first novel, "One-Eighty".
show more